Inge van der Putten nominated for the NVTAG prize 2018
Proud that our VHC colleague Inge van der Putten has been chosen as one of the 3 selected nominees to win the HTA prize 2018 of the Dutch Society for Technology Assessment in Health Care (NVTAG) for her article “Evidence-informed vaccine decision making: The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands” in Health Policy which gains insight into which information plays a role in introduction of HPV vaccination program in the Netherlands by conducting a document analysis.
Also read
-
Mimic the true nature of tissues by building complex in vitro models
Paul Wieringa (MERLN) works on innovative models to study endometriosis and the fallopian tube.
-
The Societal Impact Project
The Societal Impact Project stimulates students’ autonomous motivation to work on societal relevant problems. One of the topics this year is vaping.
-
Vaccine promotion policies for COVID-19
Two researchers from Maastricht University play a key role in translating research into vaccine policy recommendations for COVID-19: Timo Clemens, Associate Professor health policy and governance, and Inge van der Putten, Assistant Professor at the department of Health Services Research.
